- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02150538
BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study (REAL-CRT)
April 20, 2016 updated by: Gianluca Botto
This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction , by comparing the treatment with dual-chamber device .
The REAL -CRT study is designed to test the hypothesis that, in patients with atrioventricular block of I degree and standard pacing indications , biventricular pacing is superior to single stimulation of the right ventricle (RV) with optimized algorithms for minimization of pacing , as assessed by echocardiography an endpoint defined in terms of maintenance over time of left ventricular ejection fraction (LVEF ) and left ventricular end-systolic volume ( LVESV ) .
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Clinical data suggest that biventricular pacing is able to preserve the myocardial performance more effectively than the right ventricular pacing in patients with atrioventricular block and mild systolic dysfunction .
In particular, some studies have shown that medical therapy in these patients could be responsible for an increase in the cumulative percentage of chronic pacing over the 40% threshold , the threshold associated with a higher incidence of atrial fibrillation and hospitalization for heart failure and ventricular arrhythmias .
In addition , patients with pre-existing left ventricular dysfunction and indication for pacing standards have improved left ventricular systolic function , exercise capacity and quality of life as a result of biventricular pacing as compared with Right ventricular pacing .
These results suggest that biventricular pacing is a feasible option for permanent pacing in patients who have normal systolic function of the left ventricle and that this can be altered from the adverse effects of conventional Right ventricular pacing on systolic function of the left ventricle .
This reality has prompted physicians to assess the value and role of cardiac resynchronization therapy (CRT ) in patients with prolonged Atrio-Ventricular (AV) conduction .
Note the deleterious effects of chronic stimulation of the right ventricle , the optimal pacing mode should always be considered in these patients at the time of implantation .
This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction, by comparing it with the treatment with dual chamber device
Study Type
Interventional
Enrollment (Anticipated)
164
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Como, Italy, 22100
- Recruiting
- Azienda Ospedaliera Sant'Anna
-
Contact:
- Gianluca Botto
- Email: clinical-realcrt@isis.it
-
Principal Investigator:
- Gianluca Botto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with standard indications to stimulation with a high probability of paced beats according to the clinical evaluation of the investigators:
- First degree AV block (PR ≥ 220 ms) and indication for pacing
- Paroxysmal AV block second degree (Type I and Type II) associated with long-PR (PR ≥ 220 ms)
- Patient must be able to attend all required follow-up visits at the study center.
- LVEF> 35%
Exclusion Criteria :
- Patient is less than 18 years of age.
- Patients with a life expectancy less than 12 months
- Indication for CRT in class I and II
- Third-degree AV block
- Patients currently enrolled in other studies / logs
- Patients who are not able to understand and sign an informed consent
- State of current or planned pregnancy within 12 months of enrollment
- Inability to understand and complete the questionnaire QOL
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Right ventricular stimulation
patients with conventional Right Ventricular Stimulation (only RV) with optimized algorithms for minimization of pacing
|
right ventricular stimulation with dual chamber pacemaker
|
Experimental: Biventricular Stimulation
Patients with biventricular stimulation (Right Ventricle and Left Ventricle)
|
biventricular stimulation with cardiac resynchronization therapy pacemaker (crt-p)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
LVEF
Time Frame: 2 years
|
LVEF (Left Ventricular Ejection Fraction: such as the assessment of systolic function of the left ventricle)
|
2 years
|
LVESV
Time Frame: 2 years
|
LVESV (Left Ventricular End Systolic Volume: such as the assessment of left ventricular remodeling)
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
echocardiographic left ventricular measures
Time Frame: 2 years
|
. Structure and cardiac function:
|
2 years
|
Echocardiographic altrial measures
Time Frame: 2 years
|
Size of the left atrium (diameter and volume)
|
2 years
|
Clinical outcome
Time Frame: 2 years
|
Clinical benefit:
|
2 years
|
Atrial fibrillation (AF)
Time Frame: 2 years
|
Incidence of AF:
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gianluca Botto, S. Anna Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Anticipated)
December 1, 2016
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
April 15, 2014
First Submitted That Met QC Criteria
May 26, 2014
First Posted (Estimate)
May 30, 2014
Study Record Updates
Last Update Posted (Estimate)
April 21, 2016
Last Update Submitted That Met QC Criteria
April 20, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Parere Unico 86/13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on First Degree Atrioventricular Block
-
Boston Scientific CorporationTerminatedFirst Degree AV Block
-
Duke UniversityMedtronicCompleted
-
Military Institute of Medicine, PolandUnknown
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai Hospital... and other collaboratorsUnknownBradycardia | Sick Sinus Syndrome | High Degree Second Degree Atrioventricular Block | Complete Atrioventricular BlockChina
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai Hospital... and other collaboratorsUnknownBradycardia | Sick Sinus Syndrome | Complete Atrioventricular Block | High Degree Second Degree Atrioventricular Block (Disorder)China
-
Main Line HealthMedtronic; Sharpe-Strumia Research FoundationRecruitingAortic Valve Stenosis | Complete Heart Block | High Degree Second Degree Atrioventricular Block | Pacemaker-Induced CardiomyopathyUnited States
-
Quovadis AssociazioneRecruitingSinus Node Disease | Atrioventricular; Block, Second Degree (Types I and II)Italy
-
Parc de Salut MarCompletedHeart Failure | Pacemaker-Induced Cardiomyopathy | Atrioventricular Block, Second and Third DegreeSpain
-
First Affiliated Hospital of Wenzhou Medical UniversityShanghai Zhongshan Hospital; Shanghai 10th People's Hospital; The Affiliated... and other collaboratorsNot yet recruitingHeart Failure | Atrioventricular Block, Second and Third Degree | Left Bundle Branch PacingChina
-
Medical University of SilesiaMedical Research Agency, PolandNot yet recruitingAtrioventricular Block, Second and Third DegreePoland
Clinical Trials on Dual chamber pacemaker
-
Arun RaoMedtronicCompletedSinus Node DysfunctionUnited States
-
University of CalgaryCalgary Health TrustTerminatedAtrial Fibrillation | Cardiac Pacing, ArtificialCanada
-
Kafrelsheikh UniversityActive, not recruitingPacing-Induced CardiomyopathyEgypt
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Medtronic Bakken Research CenterCompletedCardiac Pacing Indication classI/IIa According AHA/ACCSpain
-
Abbott Medical DevicesRecruitingBradycardia | Arrythmia | Cardiac PacemakerUnited States
-
Columbia UniversityMedtronicTerminated
-
Boston Scientific CorporationCompletedBradycardia | Sinus Node DysfunctionUnited States, Israel, Singapore, Malaysia, Australia, Canada, China
-
Daniel L LustgartenMedtronicCompletedHeart Failure, DiastolicUnited States
-
Medtronic Cardiac Rhythm and Heart FailureTerminatedCardiac Pacemaker, Artificial | Cardiac Pacing, ArtificialCanada, United States, Israel, Italy, Qatar, China